Team finds mutations expressed within melanoma tumors that predict effective responses to a groundbreaking immunotherapy
A team led by Ludwig and Memorial Sloan Kettering (MSK) researchers has published a landmark study on the genetic basis of response to a powerful cancer therapy known as immune checkpoint blockade. Their paper, in the current ...
Nov 19, 2014
0
0